Infantile Hemangiomas An Update

被引：27

作者：

Kwon, Eun-Kyung Mary ^{[1
]}

Seefeldt, Marcia ^{[2
]}

Drolet, Beth A. ^{[2
]}

机构：

[1] Med Coll Wisconsin, Dept Dermatol, TBRC, Milwaukee, WI 53226 USA

[2] Med Coll Wisconsin, Dept Dermatol & Pediat, TBRC, Milwaukee, WI 53226 USA

来源：

AMERICAN JOURNAL OF CLINICAL DERMATOLOGY | 2013年 / 14卷 / 02期

关键词：

INTRALESIONAL CORTICOSTEROID-THERAPY; DIFFUSE NEONATAL HEMANGIOMATOSIS; LIFE-THREATENING HEMANGIOMAS; RANDOMIZED CONTROLLED-TRIAL; DYE-LASER TREATMENT; PHACE SYNDROME; PROPRANOLOL THERAPY; HEPATIC HEMANGIOMA; ENDOTHELIAL-CELLS; ORAL PROPRANOLOL;

D O I：

10.1007/s40257-013-0008-x

中图分类号：

R75 [皮肤病学与性病学];

学科分类号：

100206 ;

摘要：

Infantile hemangioma (IH) is a common vascular tumor of infancy. Although benign, infants with IH can experience complications including ulceration, visual and airway impairment, and residual scarring and disfigurement. It is often challenging for clinicians to predict which tumors are in need of systemic treatment. However, data from various demographic and other studies have revealed further insights into this tumor. This article reviews the identification, evaluation, and management of high-risk IHs, including the indications for treatment and the use of systemic treatments such as corticosteroids, beta-blockers, and vincristine.

引用

页码：111 / 123

页数：13

共 141 条

[1] Recurrence of Infantile Hemangiomas Treated with Propranolol [J].

Bagazgoitia, Lorea ;

Hernandez-Martin, Angela ;

Torrelo, Antonio .

PEDIATRIC DERMATOLOGY, 2011, 28 (06) :658-662

[2] Spastic diplegia as a complication of interferon Alfa-2a treatment of hemangiomas of infancy [J].

Barlow, CF ;

Priebe, CJ ;

Mulliken, JB ;

Barnes, PD ;

Mac Donald, D ;

Folkman, J ;

Ezekowitz, RAB .

JOURNAL OF PEDIATRICS, 1998, 132 (03) :527-530

[3] Randomised controlled study of early pulsed dye laser treatment of uncomplicated childhood haemangiomas: results of a 1-year analysis [J].

Batta, K ;

Goodyear, HM ;

Moss, C ;

Williams, HC ;

Hiller, L ;

Waters, R .

LANCET, 2002, 360 (9332) :521-527

[4]

Bennett ML, 2001, ARCH DERMATOL, V137, P1208

[5] A Novel Method for Calculating the Volume of Hemangiomas [J].

Berk, David R. ;

Berk, Elliot J. ;

Bruckner, Anna L. .

PEDIATRIC DERMATOLOGY, 2011, 28 (04) :478-482

[6] Propranolol versus Prednisone in the Treatment of Infantile Hemangiomas: A Retrospective Comparative Study [J].

Bertrand, Janie ;

McCuaig, Catherine ;

Dubois, Josee ;

Hatami, Afshin ;

Ondrejchak, Sandra ;

Powell, Julie .

PEDIATRIC DERMATOLOGY, 2011, 28 (06) :649-654

[7] Increased type 3 iodothyronine deiodinase activity in a regrown hepatic hemangioma with consumptive hypothyroidism [J].

Bessho, Kazuhiko ;

Etani, Yuri ;

Ichimori, Hiroaki ;

Miyoshi, Yoko ;

Namba, Noriyuki ;

Yoneda, Akihiro ;

Ooue, Takaharu ;

Chihara, Tsuyoshi ;

Morii, Eiichi ;

Aoki, Tomoyuki ;

Murakami, Masami ;

Mushiake, Sotaro ;

Ozono, Keiichi .

EUROPEAN JOURNAL OF PEDIATRICS, 2010, 169 (02) :215-221

[8]

Bigorre M, 2009, J PLAST RECONSTR AES, V123, P195

[9] Monoclonal expansion of endothelial cells in hemangioma: An intrinsic defect with extrinsic consequences? [J].

Bischoff, J .

TRENDS IN CARDIOVASCULAR MEDICINE, 2002, 12 (05) :220-224

[10] Management of congenital subglottic hemangioma: Trends and success over the past 17 years [J].

Bitar, MA ;

Moukarbel, RV ;

Zalzal, GH .

OTOLARYNGOLOGY-HEAD AND NECK SURGERY, 2005, 132 (02) :226-231

← 1 2 3 4 5 6 7 8 9 10 →